EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cystatin B Attenuates Cerebral Ischemia Reperfusion Injury by Inhibiting the JAK2 / STAT3 Signaling Pathway

Gang Zhou, Fengjiao Hu iD, Ju Gao, Lei Wang, Xiangbo Wu, Yu Tian, Peng Zhang, Guangming Xia, Feng Wan, Jinhua Wang iD

CNS Neuroscience & Therapeutics · 2026-04 · 32 (4)

DOI: 10.1002/cns.70818 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 29.03.2026. Verfasst von Gang Zhou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Huanggang Central Hospital of Yangtze University, Huanggang, China. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Janus Kinase 2, Signal Transduction, Reperfusion Injury. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hubei Provincial Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cerebral ischemia reperfusion injury (CIRI) poses a significant clinical and economic burden worldwide. Therefore, it is essential to identify key regulators that may improve stroke prognosis. Cystatin B (CSTB) is known to be involved in neuroprotection, inflammation modulation, and apoptosis regulation, but its specific function and mechanisms in CIRI remain unclear.

Methods

We employed gain‐ and loss‐of‐function approaches in a mouse model of transient middle cerebral artery occlusion (t/MCAO) and in cultured neurons subjected to oxygen–glucose deprivation/reperfusion (OGD/R). The effects were evaluated primarily using a combination of quantitative PCR, Western blot, and immunofluorescence staining to assess neurological deficits, inflammatory responses, and apoptosis, as well as to elucidate the underlying mechanisms.

Results

Our findings demonstrated that CSTB significantly attenuated CIRI, as evidenced by the mitigation of neurological deficits, inflammation, and apoptosis. Mechanistically, the protective effects of CSTB were associated with the suppression of the JAK2/STAT3 signaling pathway.

Conclusion

This study identifies CSTB as a novel negative regulator of CIRI. Its protective role is mediated through the inhibition of apoptosis and inflammatory responses via the JAK2/STAT3 axis, suggesting its potential as a therapeutic target for ischemic stroke.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

STAT3 Transcription FactorJanus Kinase 2Signal TransductionReperfusion InjuryBrain IschemiaNeuroprotective AgentsAnimalsMaleMiceApoptosisMice, Inbred C57BLInfarction, Middle Cerebral ArteryNeuronsCells, Cultured

Stichwörter der Autor:innen

JAK2/STAT3 pathwaycerebral ischemia reperfusion injurycystatin Bstroke

Substanzen

STAT3 Transcription FactorJanus Kinase 2Jak2 protein, mouseStat3 protein, mouseNeuroprotective Agents

Autor:innen und Institutionen

  • Department of Neurology, Huanggang Central Hospital of Yangtze University, Huanggang, China.
  • Medical Science Research Center, Zhongnan Hospital; Basic Medical School, Wuhan University, Wuhan, China.
  • Basic Medical School, Wuhan University, Wuhan, China.

ORCID-Profile: Fengjiao Hu, Jinhua Wang

Förderung

  • Hubei Provincial Natural Science Foundation of China

Zitieren

APA

Zhou, G., Hu, F., Gao, J., Wang, L., Wu, X., Tian, Y., Zhang, P., Xia, G., Wan, F., & Wang, J. (2026). Cystatin B Attenuates Cerebral Ischemia Reperfusion Injury by Inhibiting the JAK2 / STAT3 Signaling Pathway. CNS Neuroscience & Therapeutics, 32(4). https://doi.org/10.1002/cns.70818

Vancouver

Zhou G, Hu F, Gao J, Wang L, Wu X, Tian Y, et al. Cystatin B Attenuates Cerebral Ischemia Reperfusion Injury by Inhibiting the JAK2 / STAT3 Signaling Pathway. CNS Neuroscience & Therapeutics. 2026;32(4). doi:10.1002/cns.70818

BibTeX
@article{Zhou2026,
  author = {Zhou, Gang and Hu, Fengjiao and Gao, Ju and Wang, Lei and Wu, Xiangbo and Tian, Yu and Zhang, Peng and Xia, Guangming and Wan, Feng and Wang, Jinhua},
  title = {Cystatin B Attenuates Cerebral Ischemia Reperfusion Injury by Inhibiting the JAK2 / STAT3 Signaling Pathway},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2026},
  volume = {32},
  number = {4},
  doi = {10.1002/cns.70818}
}
Kostenlos starten →